Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Jounce Therapeutics Inc. logo

Jounce Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

Optionable: Yes  Market Cap: 101 M  90-day average vol: 0

Previous close: 1.93  Open: 1.91  Bid:   Ask:
52 week range    
Last updated: Friday 1st December 2023

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


JNCE Income Statement

Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles268000.0
Basic EPS total5 M-0.841.72-1.24-1.82-0.99
Basic weighted shares outstanding30 M33 M33 M35 M50 M52 M
Depreciation-4 M-4 M-4 M-3 M-3 M-2 M
Depreciation unreconciled268000.0
DepreciationAndAmortization268000.0-4 M-4 M-3 M-3 M-2 M
Diluted EPS total-0.57-0.841.66-1.24-1.82-0.99
Diluted weighted shares outstanding33 M34 M35 M50 M52 M
GeneralAndAdministrativeExpense23 M26 M28 M29 M29 M31 M
Gross operating profit72 M65 M148 M62 M27 M82 M
Income before tax-17 M-27 M57 M-44 M-91 M-51 M
Income taxes36000.046000.046000.014000.015000.0135000.0
MiscOtherSpecialCharges3 M4 M4 M1 M199000.01 M
Net income from total operations-17 M-27 M57 M-44 M-91 M-51 M
NetIncomeCommonStockholders-17 M-27 M57 M-44 M-91 M-51 M
NetIncomeContinuousOperations-17 M-27 M57 M-44 M-91 M-51 M
Operating income-19 M-31 M53 M-45 M-91 M-52 M
Operating income before depreciation (EBITDA)-25 M59 M-40 M-87 M-48 M
OperatingExpense91 M96 M95 M107 M118 M134 M
OperatingRevenue72 M65 M148 M62 M27 M82 M
Other income net-3 M-4 M-4 M-1 M-199000.0-1 M
OtherGandA23 M26 M28 M29 M29 M31 M
RentAndLandingFees23 M26 M28 M29 M29 M31 M
Research & development expense68 M70 M67 M79 M89 M103 M
ResearchExpense68 M70 M67 M79 M89 M103 M
SalariesAndWages-5 M-9 M-10 M-10 M-11 M-10 M
Selling Gen & administrative expense23 M26 M28 M29 M29 M31 M
Special income/charges-318000.0
Total Income available for interest expense (EBIT)-17 M-27 M57 M-44 M-91 M-51 M
Total common shares outstanding52 M52 M52 M52 M52 M52 M
Total net income-17 M-27 M57 M-44 M-91 M-51 M
Total ordinary shares53 M53 M53 M53 M53 M53 M
Total revenues72 M65 M148 M62 M27 M82 M
TotalExpenses91 M96 M95 M107 M118 M134 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today